WILEX

wilex-logo

WILEX a biopharmaceutical company, develops drugs and diagnostic agents to detect cancer, treat malignant tumours, and prevent metastases. Its product line includes RENCAREX, a phase III substance for the treatment of non-metastatic renal cell cancer; REDECTANE, a phase III substance for the treatment of renal mass; and MESUPRON, a phase II substance for the treatment of pancreatic and breast cancer. The company's products also comprise the MEK inhibitor WX-554, which is under Phase I clinical trial; and the other oncology projects, including PI3K inhibitor WX-037 and three antibody programmes under preclinical development. It has a strategic alliance with UCB Pharma S.A. to develop preclinical oncology portfolio. The company was founded in 1997 and is headquartered in Munich, Germany.

#SimilarOrganizations #People #Financial #Website #More

WILEX

Social Links:

Industry:
Biopharma Biotechnology Health Diagnostics

Founded:
1997-01-01

Address:
Ladenburg, Baden-Wurttemberg, Germany

Country:
Germany

Website Url:
http://www.wilex.de

Total Employee:
11+

Status:
Active

Contact:
+ 49 6203 1009 0

Email Addresses:
[email protected]

Total Funding:
65.5 M USD

Technology used in webpage:
United Domains


Similar Organizations

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

valipharma-logo

ValiPharma

ValiPharma develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer.


Current Advisors List

friedrich-bohlen_image

Friedrich Bohlen Member of the Supervisory Board @ WILEX
Board_member
2005-04-29

arie-belldegrun_image

Arie Belldegrun Chairman of the Medical Advisory Board @ WILEX
Advisor

Founder


olaf-wilhelm_image

Olaf Wilhelm

Stock Details


Company's stock symbol is ETR:WL6

Acquisitions List

Date Company Article Price
2010-11-03 Heidelberg Pharma AG Heidelberg Pharma AG acquired by WILEX N/A

Investors List

yorkville-advisors_image

Yorkville Advisors

Yorkville Advisors investment in Post-IPO Debt - WILEX

tvm-capital_image

TVM Capital

TVM Capital investment in Series C - WILEX

earlybird-venture-capital_image

Earlybird Venture Capital

Earlybird Venture Capital investment in Series C - WILEX

apax-partners_image

Apax Partners

Apax Partners investment in Series C - WILEX

earlybird-venture-capital_image

Earlybird Venture Capital

Earlybird Venture Capital investment in Venture Round - WILEX

Official Site Inspections

http://www.wilex.de

  • Host name: 89.31.143.90
  • IP address: 89.31.143.90
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "WILEX" on Search Engine